Axcella Health
Latest round
- Series E
Last raised
- Nov 2018
Total raised
- $121M
Investors
- 4
About Axcella Health
Axcella Health, Inc.Founded in 2010, Axcella Health, Inc. is headquartered in Cambridge, US. The company specializes in the development of Endogenous Metabolic Modulators, particularly targeting metabolic disorders.00 mn through an IPO on May 8, 2019, marking its strategic evolution in the biopharmaceutical sector.Axcella Health, Inc. specializes in the development of Endogenous Metabolic Modulators (EMMs), a diverse class of molecules that play a critical role in regulating human metabolism. The company’s main product offerings include AXA candidates, with the lead candidate being AXA1665, which is being developed as a therapeutic drug for hepatic encephalopathy (HE). Axcella's development platform focuses on translating complex human biology into both drug and non-drug candidates that aim to address metabolic dysregulation, a condition central to many health issues. These offerings target various applications in the liver, muscle, and blood systems.Axcella Health, Inc. operates primarily through partnerships and collaborations in the biopharmaceutical sector, focusing on clinical studies aimed at evaluating the safety and efficacy of its AXA candidates.58 mn for the year 2022. Revenue generation is structured around transactions including research grants, development partnerships with pharmaceutical companies, and potential future sales of approved drug products.Axcella Health, Inc. aims to enhance its product portfolio by continuing to develop its lead AXA candidate, AXA1665, with plans to advance clinical trials in the coming years.00 mn, which will be utilized to fund ongoing research and development initiatives, including the expansion of its clinical trials and exploration of new markets in Europe and Asia by 2024. Axcella is committed to establishing strategic partnerships to boost market penetration and facilitate the introduction of approved products into wider healthcare settings.
Who invested in Axcella Health
4 investors across 5 rounds
See all investors in Axcella Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Axcella Health
Who invested in Axcella Health?
Axcella Health has 4 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Axcella Health raised?
Axcella Health has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Axcella Health last raise money?
Axcella Health's most recent round on record is a Series E, in Nov 2018.
What does Axcella Health do?
Axcella Health is a food company.
Where is Axcella Health headquartered?
Axcella Health is headquartered in Cambridge, US.
Which VCs invest in companies like Axcella Health?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back food companies at Axcella Health's stage. Their profiles are linked below.
VCs backing food startups at Series E
Raising like Axcella Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.